U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
117151117151Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)CompletedNo Results AvailableTherapyDrug: Cilostazol, Probucol / placebo of probucolhttps://ClinicalTrials.gov/show/NCT01031667
117152117152Marital Functioning Among Combat VeteransRecruitingNo Results AvailableStress Disorders, Post-Traumatichttps://ClinicalTrials.gov/show/NCT01031654
117153117153Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Via Cognitive Interviewing and Usability TestingCompletedNo Results AvailableLymphomas|Leukemias|Multiple Cancershttps://ClinicalTrials.gov/show/NCT01031641
117154117154Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) PatientsTerminatedHas ResultsGastrointestinal Stromal TumorsDrug: Imatinib mesylate|Drug: Imatinib mesylate|Drug: Imatinib mesylatehttps://ClinicalTrials.gov/show/NCT01031628
117155117155Evaluation of the Child and Family Traumatic Stress InterventionCompletedNo Results AvailablePosttraumatic Stress DisorderBehavioral: Child and Family Traumatic Stress Interv (CFTSI)|Behavioral: Psychoeducational Comparisonhttps://ClinicalTrials.gov/show/NCT01031615
117156117156Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers PatientsCompletedNo Results AvailableGynecologic CancerBehavioral: Surveyshttps://ClinicalTrials.gov/show/NCT01031602
117157117157TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278CompletedNo Results AvailableHIV InfectionsDrug: TMC278 (Rilpivirine) LA; Placebohttps://ClinicalTrials.gov/show/NCT01031589
117158117158Postural Analysis in Patients With Knee OsteoarthritisCompletedNo Results AvailableOsteoarthritishttps://ClinicalTrials.gov/show/NCT01031576
117159117159Risk Perception in Drug-Dependent Adults With and Without SchizophreniaCompletedNo Results AvailableCocaine Dependence|Cannabis Dependence|Schizophreniahttps://ClinicalTrials.gov/show/NCT01031563
117160117160Isoflurane Preconditioning for Liver ResectionsTerminatedHas ResultsLiver DiseaseDrug: isoflurane|Other: standard of carehttps://ClinicalTrials.gov/show/NCT01031550
117161117161A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL Baxter) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the LaboratoryRecruitingNo Results AvailableTick-Borne Encephalitis|Encephalitis, Tick-Borne|Tick-Borne Disease|Glycoprotein E, Flavivirus|NSI Protein, FlavivirusBiological: FSME-IMMUN 0.5ml Baxterhttps://ClinicalTrials.gov/show/NCT01031537
117162117162Trial to Assess the Efficacy of Malaria Vaccine PfCS 102CompletedNo Results AvailablePlasmodium Falciparum MalariaBiological: PfCS102|Biological: Montanide ISA 720https://ClinicalTrials.gov/show/NCT01031524
117163117163Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum DisordersActive, not recruitingNo Results AvailableAutism Spectrum Disorder|AnxietyBehavioral: Cognitive Behavioural Therapy|Other: Social Recreationalhttps://ClinicalTrials.gov/show/NCT01031511
117164117164Palonosetron Versus Ondansetron for the Prevention of Nausea and VomitingCompletedHas ResultsAcute Myelogenous Leukemia|Chemotherapy-induced Nausea and VomitingDrug: Ondansetron|Drug: Palonosetronhttps://ClinicalTrials.gov/show/NCT01031498
117165117165Bioactive Milk Peptides and Blood PressureCompletedNo Results AvailableStage 1 HypertensionDietary Supplement: Milk peptides and plant sterols|Other: Placebohttps://ClinicalTrials.gov/show/NCT01031485
117166117166A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761CompletedNo Results AvailableInfection, Human Immunodeficiency VirusDrug: GSK2248761 formulation 1|Drug: GSK2248761 reference formulation|Drug: GSK2248761 formulation 3|Drug: GSK2248761 formulation 2 or 4https://ClinicalTrials.gov/show/NCT01031472
117167117167Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.CompletedNo Results AvailableMultiple SclerosisDrug: Betaseron (Interferon beta-1b, BAY86-5046)https://ClinicalTrials.gov/show/NCT01031459
117168117168Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedHas ResultsBreast CancerDrug: cisplatin|Drug: everolimus|Drug: paclitaxel|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01031446
117169117169Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual RealityCompletedNo Results AvailableNicotine Dependencehttps://ClinicalTrials.gov/show/NCT01031433
117170117170Dose Dense MVAC for Muscle Invasive Bladder CancerActive, not recruitingNo Results AvailableMuscle Invasive Bladder Cancer|High Risk Urothelial Carcinoma of the Upper Urinary TractsDrug: single arm dose dense MVAChttps://ClinicalTrials.gov/show/NCT01031420
117171117171Cognitive Neuroscience of Autism Spectrum DisordersRecruitingNo Results AvailableAutistic Disorder|Asperger Syndrome|Mental Retardation|Child|Adulthttps://ClinicalTrials.gov/show/NCT01031407
117172117172Frequency of Aerobic/Resistance Training in Older WomenCompletedNo Results AvailableAgingOther: Frequency of Aerobic/Resistance Training - 3 to 3https://ClinicalTrials.gov/show/NCT01031394
117173117173Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube CancerCompletedNo Results AvailableOvarian Cancer|Fallopian Tube Cancer|Primary Peritoneal CarcinomaDrug: RAD001|Drug: bevacizumabhttps://ClinicalTrials.gov/show/NCT01031381
117174117174Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableAdult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute MyeloblastDrug: cytarabine|Drug: clofarabine|Drug: filgrastim|Procedure: ex vivo-expanded cord blood progenitor cell infusion|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01031368
117175117175Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate CalciumCompletedNo Results AvailableContraception|Ovulation InhibitionDrug: Estradiol Valerate (EV) / Levomefolate Calcium (BAY98-7078)|Drug: Estradiol Valerate (EV) (BAY86-4980)|Drug: Levomefolate Calcium (BAY86-7660)https://ClinicalTrials.gov/show/NCT01031355
117176117176Early Colonoscopy for Lower Gastrointestinal (GI) BleedingTerminatedNo Results AvailableGastrointestinal HemorrhageProcedure: Early colonoscopy|Procedure: Elective colonoscopyhttps://ClinicalTrials.gov/show/NCT01031342
117177117177Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in TurkeyWithdrawnNo Results AvailableInfections, StreptococcalProcedure: Tympanocenthesis and urine collectionhttps://ClinicalTrials.gov/show/NCT01031329
117178117178Patent Ductus Arteriosus (PDA) Screening TrialCompletedNo Results AvailableDuctus Arteriosus, PatentOther: Nondisclosure of screening echocardiogram results|Other: Disclosure of screening echocardiogram resultshttps://ClinicalTrials.gov/show/NCT01031316
117179117179Immunogenicity and Safety of TETRAXIMâ„¢ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNo Results AvailableDiphtheria|Tetanus|Pertussis|PoliomyelitisBiological: DTacP-IPV combined vaccine (TETRAXIMâ„¢)https://ClinicalTrials.gov/show/NCT01031303
117180117180Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis CravingWithdrawnNo Results AvailableCannabis UseDevice: Repetitive Transcranial Magnetic Stimulationhttps://ClinicalTrials.gov/show/NCT01031290

* Görseller ve İçerik tekif hakkına sahip olabilir